FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

63261000000102: Tumour and germline whole genome sequencing for anaplastic lymphoma kinase positive anaplastic large cell lymphoma (procedure)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Jun 2019. Module: SNOMED CT United Kingdom clinical extension module

Descriptions:

Id Description Lang Type Status Case? Module
1089211000000119 ALK (anaplastic lymphoma kinase) positive ALCL (anaplastic large cell lymphoma) tumour and germline WGS (whole genome sequencing) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom clinical extension module
1089221000000113 Tumour and germline whole genome sequencing for anaplastic lymphoma kinase positive anaplastic large cell lymphoma (procedure) en Fully specified name Active Entire term case insensitive SNOMED CT United Kingdom clinical extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
ALK (anaplastic lymphoma kinase) positive ALCL (anaplastic large cell lymphoma) tumour and germline WGS (whole genome sequencing) Method Evaluation - action false Inferred relationship Existential restriction modifier
ALK (anaplastic lymphoma kinase) positive ALCL (anaplastic large cell lymphoma) tumour and germline WGS (whole genome sequencing) Is a Tumour and germline whole genome sequencing (procedure) true Inferred relationship Existential restriction modifier
ALK (anaplastic lymphoma kinase) positive ALCL (anaplastic large cell lymphoma) tumour and germline WGS (whole genome sequencing) Method Evaluation - action true Inferred relationship Existential restriction modifier 1

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start